|
|
||||||||
Division of Critical Care Medicine, Department of Medicine, and Department of Physiology and Biophysics, Rosalind Franklin University of Medicine and Science, North Chicago; and Section of Critical Care Medicine, Medical Service, North Chicago Veterans Affairs Medical Center, North Chicago, Illinois
Submitted 24 November 2004 ; accepted in final form 5 February 2005
When given during closed-chest resuscitation, cariporide (4-isopropyl-methylsulfonylbenzoyl-guanidine methanesulfonate; a selective inhibitor of the Na+/H+ exchanger isoform-1) enables generation of viable perfusion pressures with less depth of compression. We hypothesized that this effect results from greater blood flows generated for a given depth of compression. Two series of 14 rats each underwent 10 min of untreated ventricular fibrillation followed by 8 min of chest compression before defibrillation was attempted. Compression depth was adjusted to maintain an aortic diastolic pressure (ADP) between 26 and 28 mmHg in the first series and between 36 and 38 mmHg in the second series. Within each series, rats were randomized to receive cariporide (3 mg/kg) or NaCl (0.9%; control) before chest compression was started. Blood flow was measured using 15-µm fluorescent microspheres. Less depth of compression was required to maintain the target ADP when cariporide was present in both series 1 (13.6 ± 1.2 vs. 16.6 ± 1.2 mm; P < 0.001) and series 2 (15.3 ± 1.0 vs. 18.9 ± 1.5 mm; P < 0.001). Despite less compression depth, the cardiac index in cariporide-treated rats was comparable to control rats in series 1 (11.1 ± 0.7 vs. 11.3 ± 1.4 ml·min1·kg1; P = not significant) but higher in series 2 (15.5 ± 2.3 vs. 9.9 ± 1.4 ml·min1·kg1; P < 0.05). Increases in compression depth (from series 1 to series 2) increased myocardial, cerebral, and adrenal blood flow in cariporide-treated rats. We conclude that cariporide enhances the efficacy of closed-chest resuscitation by leftward shift of the flow-depth relationship.
ventricular fibrillation; cardiopulmonary resuscitation; defibrillation; sodium-hydrogen antiporter; fluorescent microspheres
This article has been cited by other articles:
![]() |
J. Radhakrishnan, I. M. Ayoub, and R. J. Gazmuri Activation of caspase-3 may not contribute to postresuscitation myocardial dysfunction Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1164 - H1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gautier, D. Antier, P. Bonnet, J.-L. L. Net, G. Hanton, and V. Eder Continuous inhalation of carbon monoxide induces right ventricle ischemia and dysfunction in rats with hypoxic pulmonary hypertension Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1046 - H1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, J. Radhakrishnan, I. M. Ayoub, J. D. Kolarova, D. M. Taglieri, and R. J. Gazmuri Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury J Appl Physiol, July 1, 2007; 103(1): 55 - 65. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |